{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:05:16Z","timestamp":1790395516361,"version":"4.1.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ando.2012.09.001","type":"journal-article","created":{"date-parts":[[2012,10,15]],"date-time":"2012-10-15T15:00:58Z","timestamp":1350313258000},"page":"469-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Hormonal contraception in women at risk of vascular and metabolic disorders: Guidelines of the French Society of Endocrinology"],"prefix":"10.1016","volume":"73","author":[{"given":"Pierre","family":"Gourdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bachelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Catteau-Jonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Christin-Ma\u00eetre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Conard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Fredenrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gompel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Lamiche-Lorenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Plu-Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vambergue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Verg\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Kerlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2012.09.001_bib0005","series-title":"Activit\u00e9 sexuelle, infections sexuellement transmissibles, contraception","author":"Moreau","year":"2008"},{"key":"10.1016\/j.ando.2012.09.001_bib0010","series-title":"Medical eligibility criteria for contraceptive use. Fourth edition, 2009. A WHO family planning cornerstone","author":"WHO","year":"2009"},{"key":"10.1016\/j.ando.2012.09.001_bib0015","unstructured":"Centers for disease control and prevention. US. medical eligibility criteria for contraceptive use, 2010: adapted from the World Health Organization medical eligibility criteria for contraceptive use, 4th edition. MMWR Recomm Rep 2010:1\u201386\u00a0p."},{"key":"10.1016\/j.ando.2012.09.001_bib0020","first-page":"1","article-title":"La medicalisation croissante de la contraception en France","volume":"381","author":"Leridon","year":"2002","journal-title":"Popul Soc"},{"issue":"3\u20134","key":"10.1016\/j.ando.2012.09.001_bib0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3917\/pope.403.0347","article-title":"Contraception et avortement en France dans les ann\u00e9es 2000","volume":"59","author":"Bajos","year":"2004","journal-title":"Population"},{"key":"10.1016\/j.ando.2012.09.001_bib0030","series-title":"De la contraception \u00e0 l\u2019avortement. Sociologie des grossesses non pr\u00e9vues","author":"Bajos","year":"2002"},{"key":"10.1016\/j.ando.2012.09.001_bib0035","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/humrep\/deg215","article-title":"Contraception: from accessibility to efficiency","volume":"18","author":"Bajos","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2012.09.001_bib0040","first-page":"1","article-title":"Pourquoi le nombre d\u2019avortements n\u2019a-t-il pas baiss\u00e9 en France depuis 30ans\u00a0?","volume":"407","author":"Bajos","year":"2004","journal-title":"Popul Soc"},{"key":"10.1016\/j.ando.2012.09.001_bib0045","first-page":"1","article-title":"Les interruptions volontaires de grossesse en 2007. \u00c9tudes et r\u00e9sultats","volume":"765","author":"Vilain","year":"2009","journal-title":"DREES"},{"key":"10.1016\/j.ando.2012.09.001_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2007.09.001","article-title":"Reducing unintended pregnancy in the United States","volume":"77","author":"Trussell","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2010.03.011","article-title":"Patterns of contraceptive use before and after an abortion: results from a nationally representative survey of women undergoing an abortion in France","volume":"82","author":"Moreau","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2007.09.013","article-title":"Estimates of contraceptive failure from the 2002 National Survey of Family Growth","volume":"77","author":"Kost","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0065","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/humrep\/dem184","article-title":"Contraceptive failure rates in France: results from a population-based survey","volume":"22","author":"Moreau","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2012.09.001_bib0070","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/humrep\/dep027","article-title":"Frequency of discontinuation of contraceptive use: results from a French population-based cohort","volume":"24","author":"Moreau","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2012.09.001_bib0075","first-page":"CD003989","article-title":"20\u03bcg versus>20\u03bcg estrogen combined oral contraceptives for contraception","volume":"1","author":"Gallo","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2012.09.001_bib0080","first-page":"355","article-title":"Unintended pregnancies and use, misuse and discontinuation of oral contraceptives","volume":"40","author":"Rosenberg","year":"1995","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ando.2012.09.001_bib0085","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0090","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of estrogen dose and progestin type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2012.09.001_bib0095","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"issue":"Suppl. 3","key":"10.1016\/j.ando.2012.09.001_bib0100","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S0049-3848(11)70009-3","article-title":"Epidemiology of the contraceptive pill and venous thromboembolism","volume":"127","author":"Hannaford","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.ando.2012.09.001_bib0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2010.04148.x","article-title":"Hormone therapies and venous thromboembolism: where are we now?","volume":"9","author":"van Hylckama Vlieg","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ando.2012.09.001_bib0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2012.09.001_bib0115","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2012.09.001_bib0120","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2012.09.001_bib0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1657546","article-title":"Effect of oral contraceptives on hemostasis variables","volume":"78","author":"Kluft","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ando.2012.09.001_bib0130","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2012.09.001_bib0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ando.2012.09.001_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ando.2012.09.001_bib0145","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1538-7836.2004.00894.x","article-title":"Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives","volume":"2","author":"Alhenc-Gelas","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ando.2012.09.001_bib0150","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1538-7836.2008.02863.x","article-title":"Different effects of oral contraceptives containing different progestins on protein\u00a0S and tissue factor pathway inhibitor","volume":"6","author":"van Vliet","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ando.2012.09.001_bib0155","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ando.2012.09.001_bib0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(02)00436-5","article-title":"Effect of four different oral contraceptives on various sex hormones and serum-binding globulins","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/humrep\/deh612","article-title":"Association between sex hormone-binding globulin levels and activated protein\u00a0C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestins","volume":"20","author":"van Vliet","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2012.09.001_bib0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2008.11.002","article-title":"Sex hormone-binding globulin: an adequate surrogate marker for venous thromboembolism in women using new hormonal contraceptives","volume":"79","author":"van Vliet","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0180","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2012.09.001_bib0185","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","article-title":"Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis","volume":"131","author":"Wu","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ando.2012.09.001_bib0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35\u03bcg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0200","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/AOG.0b013e3181626d1b","article-title":"Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial","volume":"111","author":"Johnson","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2007.10.004","article-title":"Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables","volume":"77","author":"Kluft","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.thromres.2008.04.022","article-title":"Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study","volume":"123","author":"Fleischer","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.ando.2012.09.001_bib0215","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.contraception.2009.05.131","article-title":"Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis","volume":"81","author":"van Vliet","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/00016340902730375","article-title":"Limited knowledge on progestin-only contraception and risk of venous thromboembolism","volume":"88","author":"Bergendal","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ando.2012.09.001_bib0225","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0010-7824(01)00306-7","article-title":"Contraceptives and cerebral thrombosis: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13625189909064007","article-title":"Oral progestin-only contraceptives and cardiovascular risk: results from the Transnational Study on oral contraceptives and the health of young women","volume":"4","author":"Heinemann","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ando.2012.09.001_bib0235","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0650","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestin-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study","volume":"57","author":"World Health Organization Collaborative Study of cardiovascular disease and steroid hormone contraception","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0245","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ando.2012.09.001_bib0250","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM198811173192004","article-title":"A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases","volume":"319","author":"Stampfer","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2012.09.001_bib0255","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","article-title":"Contraceptive hormone use and cardiovascular disease","volume":"53","author":"Shufelt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ando.2012.09.001_bib0260","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.fertnstert.2005.01.084","article-title":"Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit","volume":"83","author":"Stefanick","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2012.09.001_bib0265","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bmj.318.7198.1579","article-title":"Oral contraceptives and myocardial infarction: results of the MICA case-control study","volume":"318","author":"Dunn","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2012.09.001_bib0270","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2012.09.001_bib0655","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study","volume":"349","author":"World Health Organization Collaborative Study of cardiovascular disease and steroid hormone contraception","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2012.09.001_bib0280","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.fertnstert.2006.11.206","article-title":"A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women","volume":"88","author":"Margolis","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2012.09.001_bib0285","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/bmj.306.6883.956","article-title":"Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study","volume":"306","author":"Lidegaard","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2012.09.001_bib0290","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/bmj.310.6983.830","article-title":"Case-control study of migraine and risk of ischemic stroke in young women","volume":"310","author":"Tzourio","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2012.09.001_bib0295","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0010-7824(98)00036-5","article-title":"Norplant implants and cardiovascular disease","volume":"57","author":"Petitti","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0300","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/STROKEAHA.108.538405","article-title":"Progestogen-only contraceptives and the risk of stroke: a meta-analysis","volume":"40","author":"Chakhtoura","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ando.2012.09.001_bib0305","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archinte.161.8.1065","article-title":"Low-dose oral contraceptive use and the risk of myocardial infarction","volume":"161","author":"Rosenberg","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2012.09.001_bib0310","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1471-0528.1991.tb15397.x","article-title":"Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study","volume":"98","author":"Thorogood","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0315","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jc.2010-2065","article-title":"Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis","volume":"96","author":"Chakhtoura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2012.09.001_bib0660","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2010.08.012","article-title":"Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients","volume":"83","author":"Chabbert-Buffet","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0325","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.gyobfe.2008.02.006","article-title":"Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?","volume":"36","author":"Plu-Bureau","year":"2008","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.ando.2012.09.001_bib0330","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0015-0282(16)58321-6","article-title":"Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis","volume":"65","author":"Lobo","year":"1996","journal-title":"Fertil Steril"},{"issue":"Suppl.","key":"10.1016\/j.ando.2012.09.001_bib0335","first-page":"71","article-title":"Effects of oral contraceptives on circulating lipids and lipoproteins: maximizing benefit, minimizing risk","volume":"34","author":"LaRosa","year":"1989","journal-title":"Int J Fertil"},{"key":"10.1016\/j.ando.2012.09.001_bib0340","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study","volume":"92","author":"Sitruk-Ware","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2012.09.001_bib0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.04.027","article-title":"Transdermal hormonal contraception: benefits and risks","volume":"197","author":"Burkman","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0350","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7326\/0003-4819-138-1-200301070-00013","article-title":"Prescribing oral contraceptives for women older than 35years of age","volume":"138","author":"Seibert","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2012.09.001_bib0355","unstructured":"Anaes. Recommandations pour la pratique clinique. Strat\u00e9gies de choix des m\u00e9thodes contraceptives chez la femme. Anaes-Afssaps-Inpes. Service des recommandations professionnelles de l\u2019Anaes 2004."},{"key":"10.1016\/j.ando.2012.09.001_bib0360","first-page":"478","article-title":"Niveau tensionnel moyen et pr\u00e9valence de l\u2019hypertension art\u00e9rielle chez les adultes de 18 \u00e0 74ans, ENNS 2006\u20132007","volume":"49\u201350","author":"Godet-Thobie","year":"2008","journal-title":"BEH"},{"key":"10.1016\/j.ando.2012.09.001_bib0365","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.ando.2012.09.001_bib0370","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2012.09.001_bib0375","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.contraception.2010.02.009","article-title":"Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome","volume":"82","author":"Kriplani","year":"2010","journal-title":"Contraception"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ando.2012.09.001_bib0380","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/13625180500434889","article-title":"Chlormadinone acetate (CMA) in oral contraception\u2013a new opportunity","volume":"10","author":"Bouchard","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ando.2012.09.001_bib0385","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.164.7.741","article-title":"Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence","volume":"164","author":"Chan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2012.09.001_bib0390","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2012.09.001_bib0395","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2010.02.014","article-title":"Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States","volume":"82","author":"Curtis","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0400","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0010-7824(94)90099-X","article-title":"Hemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives","volume":"49","author":"Fruzzetti","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0405","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9378(96)70440-4","article-title":"Smoking and cycle control among oral contraceptive users","volume":"174","author":"Rosenberg","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0410","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives: a meta-analysis","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2012.09.001_bib0415","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ando.2012.09.001_bib0420","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bmj.2.6089.729","article-title":"Oral contraceptive use and venous thromboembolism: absence of an effect of smoking","volume":"2","author":"Lawson","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.ando.2012.09.001_bib0425","doi-asserted-by":"crossref","first-page":"c2573","DOI":"10.1136\/bmj.c2573","article-title":"Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviours","volume":"340","author":"Bajos","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2012.09.001_bib0665","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","author":"World Health Organization Collaborative Study of cardiovascular disease and steroid hormone contraception","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2012.09.001_bib0435","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0010-7824(98)00033-X","article-title":"Oral contraceptives and venous thromboembolism. A case-control study","volume":"57","author":"Lidegaard","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0670","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study","volume":"346","author":"World Health Organization Collaborative Study of cardiovascular disease and steroid hormone contraception","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2012.09.001_bib0445","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","article-title":"Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations","volume":"139","author":"Pomp","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ando.2012.09.001_bib0450","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low-estrogen combined estrogen\u2013progestin oral contraceptives","volume":"70","author":"Sidney","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2005.04.002","article-title":"Family planning for obese women: challenges and opportunities","volume":"72","author":"Grimes","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0460","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.contraception.2008.11.017","article-title":"Obesity and oral contraceptive pill failure","volume":"79","author":"Trussell","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0465","first-page":"820","article-title":"Body weight and risk of oral contraceptive failure","volume":"99","author":"Holt","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0470","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.AOG.0000149155.11912.52","article-title":"Body mass index, weight, and oral contraceptive failure risk","volume":"105","author":"Holt","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0475","first-page":"CD008452","article-title":"Hormonal contraceptives for contraception in overweight or obese women","volume":"7","author":"Lopez","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2012.09.001_bib0480","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2012.09.001_bib0485","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1016\/S0010-7824(98)00120-6","article-title":"Pharmacokinetics of implanon. An integrated analysis","volume":"58","author":"Huber","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0675","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2011.02.009","article-title":"Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel","volume":"84","author":"Glasier","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0495","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1381\/096089203765887697","article-title":"Contraceptive treatment after biliopancreatic diversion needs consensus","volume":"13","author":"Gerrits","year":"2003","journal-title":"Obes Surg"},{"key":"10.1016\/j.ando.2012.09.001_bib0500","first-page":"91","article-title":"Sex hormone levels and intestinal absorption of estradiol and D-norgestrel in women following bypass surgery for morbid obesity","volume":"6","author":"Andersen","year":"1982","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ando.2012.09.001_bib0505","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0889-8553(21)00311-3","article-title":"Oral contraceptive absorption and sex hormone binding globulins in obese women: effects of jejunoileal bypass","volume":"16","author":"Victor","year":"1987","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.ando.2012.09.001_bib0510","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/aje\/126.2.202","article-title":"Adverse influences of alcohol, smoking, and oral contraceptive use on cardiovascular risk factors during transition to adulthood","volume":"126","author":"Croft","year":"1987","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ando.2012.09.001_bib0515","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9378(90)90587-W","article-title":"Effects of oral contraceptives on carbohydrate and lipid metabolisms in a healthy population: the Telecom study","volume":"163","author":"Simon","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0520","first-page":"CD006133","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus","volume":"2","author":"Lopez","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2012.09.001_bib0525","first-page":"925","article-title":"Evaluation of routine diabetes and lipid screening after age 35 in candidates for or current users of oral contraceptives","volume":"82","author":"Kjos","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0530","first-page":"1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestin, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2012.09.001_bib0535","doi-asserted-by":"crossref","unstructured":"WHO Special Programme of Research, Development and Research training in Human Reproduction. Task force on oral contraceptives. A randomized double-blind study of the effects of two low-dose combined oral contraceptives on biochemical aspects. Report from a seven-centred study. Contraception 1985;32:223\u20136.","DOI":"10.1016\/0010-7824(85)90046-0"},{"key":"10.1016\/j.ando.2012.09.001_bib0540","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0010-7824(88)90021-2","article-title":"Metabolic changes in women using a long-acting monthly oral contraceptive and return of ovulation on discontinuation","volume":"37","author":"Yu","year":"1988","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0545","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/07853899509031958","article-title":"Influence of oral contraceptive use on lipoprotein (a) and other coronary heart disease risk factors","volume":"27","author":"Porkka","year":"1995","journal-title":"Ann Med"},{"key":"10.1016\/j.ando.2012.09.001_bib0550","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2337\/diacare.25.6.1027","article-title":"Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA Study. Coronary artery risk development in young adults","volume":"25","author":"Kim","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2012.09.001_bib0555","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0010-7824(98)00018-3","article-title":"Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism","volume":"57","author":"Crook","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0560","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2009.01.012","article-title":"Route of administration of contraceptives containing desogestrel\/etonorgestrel and insulin sensitivity: a prospective randomized study","volume":"80","author":"Cagnacci","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0565","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/BF00401427","article-title":"Oral contraceptive use and the risk of type\u00a02 (non-insulin-dependent) diabetes mellitus in a large prospective study of women","volume":"35","author":"Rimm","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.ando.2012.09.001_bib0570","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diacare.20.3.330","article-title":"A prospective study of oral contraceptives and NIDDM among U.S. women","volume":"20","author":"Chasan-Taber","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2012.09.001_bib0575","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.contraception.2003.10.015","article-title":"Oral contraceptive use and risk of diabetes among Chinese women","volume":"69","author":"Rosenthal","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0580","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type\u00a02 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2012.09.001_bib0585","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.contraception.2008.10.013","article-title":"How does gestational diabetes affect postpartum contraception in nondiabetic primiparous women?","volume":"79","author":"Beydoun","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2012.09.001_bib0590","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0002-9378(85)90460-0","article-title":"Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes","volume":"153","author":"Skouby","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0595","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jama.280.6.533","article-title":"Contraception and the risk of type\u00a02 diabetes mellitus in Latina women with prior gestational diabetes mellitus","volume":"280","author":"Kjos","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2012.09.001_bib0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2008.09.034","article-title":"Risk factors for type\u00a02 diabetes among women with gestational diabetes: a systematic review","volume":"122","author":"Baptiste-Roberts","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2012.09.001_bib0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.03.029","article-title":"Intermediate-term glucose tolerance in women with a history of gestational diabetes: natural history and potential associations with breastfeeding and contraception","volume":"198","author":"Nelson","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ando.2012.09.001_bib0610","first-page":"CD003990","article-title":"Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2","volume":"4","author":"Visser","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2012.09.001_bib0615","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/09513590600624317","article-title":"Contraception in perimenopausal women with diabetes mellitus","volume":"22","author":"Grigoryan","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ando.2012.09.001_bib0620","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jama.1994.03510380055037","article-title":"Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus","volume":"271","author":"Garg","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2012.09.001_bib0625","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.2337\/diacare.22.12.1984","article-title":"Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of diabetic retinopathy","volume":"22","author":"Klein","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2012.09.001_bib0630","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.2337\/diacare.28.8.1988","article-title":"Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy","volume":"28","author":"Ahmed","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2012.09.001_bib0680","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","article-title":"Ischemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study","volume":"348","author":"World Health Organization Collaborative Study of cardiovascular disease and steroid hormone contraception","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2012.09.001_bib0640","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199607043350102","article-title":"Stroke in users of low-dose oral contraceptives","volume":"335","author":"Petitti","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2012.09.001_bib0645","first-page":"43","article-title":"Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus","volume":"49","author":"Petersen","year":"2002","journal-title":"Dan Med Bull"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426612011584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426612011584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:46:27Z","timestamp":1757717187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426612011584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":129,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0003426612011584"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2012.09.001","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal contraception in women at risk of vascular and metabolic disorders: Guidelines of the French Society of Endocrinology","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2012.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}